Yannick Arimone
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 8
-
- Drug-Induced Hepatotoxicity and Protection 2
- Drug-Induced Adverse Reactions 2
- Co-authors
- Françoise Haramburu (8 shared papers)Ghada Miremont‐Salamé (6 shared papers)Annie Fourrier‐Réglat (4 shared papers)Nicholas Moore (4 shared papers)Bernard Bégaud (5 shared papers)Hélène Théophile (6 shared papers)Mathiéu Molimard (3 shared papers)Bruno Brochet (1 shared paper)
- Journals
- Journal of Clinical Epidemiology (2 papers)Drug Safety (2 papers)European Journal of Clinical Pharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)Multiple Sclerosis Journal (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Yannick Arimone
11 papers receiving 565 citations
Peers
Comparison fields: 5 of 72
- Toxicology 186
- Geriatrics and Gerontology 31
- Pathology and Forensic Medicine 124
- Pharmacology 51
- Pharmacology 85
Countries citing papers authored by Yannick Arimone
This map shows the geographic impact of Yannick Arimone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Arimone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Arimone more than expected).
Fields of papers citing papers by Yannick Arimone
This network shows the impact of papers produced by Yannick Arimone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Arimone. The network helps show where Yannick Arimone may publish in the future.
Co-authors
The 24 scholars most cited alongside Yannick Arimone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 122 | |
| 2 | 2005 | 77 | |
| 3 | 2013 | 62 | |
| 4 | 2007 | 58 | |
| 5 | 2011 | 49 | |
| 6 | 2008 | 48 | |
| 7 | 2006 | 44 | |
| 8 | 2010 | 43 | |
| 9 | 2013 | 36 | |
| 10 | 2012 | 21 | |
| 11 | 2015 | 20 |
About Yannick Arimone
Yannick Arimone is a scholar working on Toxicology, Pharmacology, Pharmacology, Surgery and Pathology and Forensic Medicine, having authored 11 papers that have together received 580 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Drug-Induced Adverse Reactions (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Adrenal and Paraganglionic Tumors (1 paper), Multiple Sclerosis Research Studies (1 paper) and Olfactory and Sensory Function Studies (1 paper). The work is most often cited by research in Toxicology (186 citations), Geriatrics and Gerontology (31 citations), Pathology and Forensic Medicine (124 citations), Pharmacology (51 citations) and Pharmacology (85 citations). Yannick Arimone has collaborated with scholars based in France and United States. Frequent co-authors include Françoise Haramburu, Ghada Miremont‐Salamé, Annie Fourrier‐Réglat, Nicholas Moore, Bernard Bégaud, Hélène Théophile, Mathiéu Molimard, Bruno Brochet, Klaus G. Petry and M. Bonnet. Their work appears in journals such as Journal of Clinical Epidemiology, Drug Safety, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Multiple Sclerosis Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.